http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101819245-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate | 2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101819245-B1 |
titleOfInvention | Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives |
abstract | The present invention relates to a process for the preparation of N- (5-t-butyl-isoxazol-3-yl) -N '- {4- [7- (2-morpholin- ] [1,3] benzothiazol-2-yl] phenyl} urea, or a pharmaceutically acceptable salt, solvate, hydrate or polymorph thereof. N - {4- [7- (2-morpholin-4-yl-ethoxy) imidazo [2,1-b] [1 , 3] benzothiazol-2-yl] phenyl} urea is useful for treating, preventing and / or managing diseases or disorders including, but not limited to, proliferative diseases, FLT-3 mediated diseases and cancers. N - {4- [7- (2-morpholin-4-yl-ethoxy) imidazo [2,1-b] [1 , 3] benzothiazol-2-yl] phenyl} urea is shown in the following structure: Formula I |
priorityDate | 2009-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 370.